“Experience of Using Stereotactic Ablative Radiotherapy for Radical Treatment of Low and Intermediate Risk Prostate Cancer” (2024) Voprosy onkologii, 70(2), pp. 292–298. doi:10.37469/0507-3758-2024-70-2-292-298.